Skip to main content

Pfizer Oncology

2022 Breast Cancer Guide to Patient Support Services

Pfizer Oncology Together

877-744-5675

Pfizer offers Pfizer Oncology Together, a patient support program to help patients access their prescribed Pfizer Oncology medications, identify financial assistance options, and connect patients to a dedicated Care Champion. A list of Pfizer Oncology medications and their related assistance programs is provided in the Table.

Pfizer Oncology Together

Pfizer Oncology Together offers the Pfizer Oncology Together Co-Pay Savings Program, the Pfizer Patient Assistance Program, and the Care Champion Program.

Pfizer Oncology Together Co-Pay Savings Program

Copay savings are available for eligible, commercially insured patients who are prescribed certain Pfizer Oncology oral or injectable medications. Limits, terms, and conditions apply depending on the medication prescribed. Click here to learn more or to enroll your patient in the Pfizer Oncology Together Co-Pay Savings Program.

Pfizer Patient Assistance Program

Through the Pfizer Patient Assistance Program, uninsured patients may receive free medication for up to 1 calendar year, while underinsured patients are enrolled through the end of the calendar year. To be evaluated for assistance through this program, you and your patient must each submit a completed enrollment form. Patients must also provide proof of income, such as the prior year’s tax return, a W-2 form, or paycheck stub. Patients must also:

  • Have a valid prescription from a healthcare provider licensed in the United States or a US territory for a Pfizer medication
  • Have no prescription coverage, or not enough coverage, to pay for their Pfizer medication
  • Meet certain income limits, which are subject to change on an annual basis and will vary depending on household size
  • Reside in the United States or a US territory
  • Not be treated in an inpatient setting of care, such as a hospital or nursing home.

Click here to learn more or to enroll your patient in the Pfizer Patient Assistance Program.

Care Champion Program

The Care Champion Program is a free patient support program for patients prescribed a Pfizer Oncology medication. Patients are partnered with a dedicated Care Champion who has social work experience and can provide resources that may help with some of their daily challenges, no matter where they are in the treatment journey. Click here to learn more or to enroll your patient in the Care Champion Program.

Free Trial Vouchers

Patients who have been newly prescribed certain Pfizer Oncology medications may be able to start therapy with a free trial voucher. Click here to learn more or to find out which medications offer trial vouchers, or see Table.

TABLE Pfizer Breast Cancer Drugs

Drugs
Indications
Patient support programs

Drug
Aromasin (exemestane) tablets
Indications
Adjuvant treatment of postmenopausal women with ER-positive early breast cancer who have received 2 to 3 years of tamoxifen and are switched to Aromasin for completion of a total of 5 consecutive years of adjuvant hormonal therapy; treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy
Patient support programs

Drug
Ellence (epirubicin hydrochloride) injection
Indications
Breast cancer adjuvant therapy in patients with evidence of axillary node tumor involvement after primary resection
Patient support programs

Drug
Ibrance (palbociclib)
Indications
Treatment of adult patients with HR-positive, HER2-negative advanced or metastatic breast cancer in combination with either an aromatase inhibitor as initial endocrine-based therapy in postmenopausal women or in men or fulvestrant in patients with disease progression following endocrine therapy
Patient support programs

Drug
Talzenna (talazoparib)
Indications
HER2-negative locally advanced or metastatic breast cancer with BRCA mutations
Patient support programs

Drug
Trazimera (trastuzumab-qyyp)
Indications
Treatment of HER2-overexpressing breast cancer
Patient support programs

Drug
Zinecard (dexrazoxane)
Indications
Reduce doxorubicin-induced cardiomyopathy in metastatic breast cancer
Patient support programs

ER indicates estrogen receptor; HR, hormone receptor.